Literature DB >> 10998146

Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells.

M Oka1, H Nagai, H Ando, M Fukunaga, M Matsumura, K Araki, W Ogawa, T Miki, M Sakaue, K Tsukamoto, H Konishi, U Kikkawa, M Ichihashi.   

Abstract

The involvement of the phosphatidylinositol 3-kinase pathway in the regulation of melanogenesis was examined using human G361 melanoma cells. In the cells treated with wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, the melanin content increased concomitant with the elevated protein level of tyrosinase, a key enzyme in melanogenesis. Northern blot analysis revealed that the mRNA level of tyrosinase increased transiently on treatment of the cells with the phosphatidylinositol 3-kinase inhibitor. When the cells were infected with the adenovirus vector encoding the mutant adapter subunit of phosphatidylinositol 3-kinase, which acts as a dominant negative of phosphatidylinositol 3-kinase, both the melanin content and the expression of tyrosinase increased. In cells infected with the adenovirus vector encoding the constitutively active mutant of the lipid kinase, a decrease in melanin content as well as reduced expression of tyrosinase was observed. In cells expressing the constitutively active mutant of the serine-threonine protein kinase Akt, one of the downstream targets of phosphatidylinositol 3-kinase, the melanin content decreased as in the cells overproducing the constitutively active mutant of phosphatidylinositol 3-kinase. These results indicate that phosphatidylinositol 3-kinase regulates melanogenesis by modulating the expression of tyrosinase, and that activation of Akt is sufficient for suppression of melanin production in G361 melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998146     DOI: 10.1046/j.1523-1747.2000.00095.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  26 in total

1.  Docosahexaenoic acid inhibits melanin synthesis in murine melanoma cells in vitro through increasing tyrosinase degradation.

Authors:  Marie Carmel Balcos; Su Yeon Kim; Hyo-soon Jeong; Hye-young Yun; Kwang Jin Baek; Nyoun Soo Kwon; Kyoung-chan Park; Dong-seok Kim
Journal:  Acta Pharmacol Sin       Date:  2014-02-24       Impact factor: 6.150

2.  Melanogenesis inhibition in mice using a low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser: a pilot study.

Authors:  Jae-Hui Nam; Joon Hong Min; Wang-Kyun Kim; Sunmin Yim; Won-Serk Kim
Journal:  Lasers Med Sci       Date:  2017-04-20       Impact factor: 3.161

3.  Melanogenesis inhibitory effect of aerial part of Pueraria thunbergiana in vitro and in vivo.

Authors:  EunByeol Han; BoYoon Chang; DaeSung Kim; HyoungKwon Cho; SungYeon Kim
Journal:  Arch Dermatol Res       Date:  2014-07-26       Impact factor: 3.017

4.  WIPI1 coordinates melanogenic gene transcription and melanosome formation via TORC1 inhibition.

Authors:  Hsiang Ho; Rubina Kapadia; Sejad Al-Tahan; Safoora Ahmad; Anand K Ganesan
Journal:  J Biol Chem       Date:  2011-02-11       Impact factor: 5.157

5.  [6]-Shogaol inhibits melanogenesis in B16 mouse melanoma cells through activation of the ERK pathway.

Authors:  Cheng Yao; Jang-hee Oh; Inn Gyung Oh; Chi-hyun Park; Jin Ho Chung
Journal:  Acta Pharmacol Sin       Date:  2012-11-05       Impact factor: 6.150

6.  Potential redox-sensitive Akt activation by dopamine activates Bad and promotes cell death in melanocytes.

Authors:  Hye-Ryung Choi; Jung-Won Shin; Hyun-Kyoung Lee; Jin-Young Kim; Chang-Hun Huh; Sang-Woong Youn; Kyoung Chan Park
Journal:  Oxid Med Cell Longev       Date:  2010 May-Jun       Impact factor: 6.543

7.  Involvement of mTOR signaling in sphingosylphosphorylcholine-induced hypopigmentation effects.

Authors:  Hyo-Soon Jeong; Seung Hoon Lee; Hye-Young Yun; Kwang Jin Baek; Nyoun Soo Kwon; Kyoung-Chan Park; Dong-Seok Kim
Journal:  J Biomed Sci       Date:  2011-08-13       Impact factor: 8.410

8.  A potent inhibitor of SIK2, 3, 3', 7-trihydroxy-4'-methoxyflavon (4'-O-methylfisetin), promotes melanogenesis in B16F10 melanoma cells.

Authors:  Ayako Kumagai; Nanao Horike; Yudai Satoh; Tatsuya Uebi; Tsutomu Sasaki; Yumi Itoh; Yoshiyuki Hirata; Kozue Uchio-Yamada; Kazuo Kitagawa; Shinichi Uesato; Hidehisa Kawahara; Hiroshi Takemori; Yasuo Nagaoka
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

9.  Conditioned Media from Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Inhibits Melanogenesis by Promoting Proteasomal Degradation of MITF.

Authors:  Eun Sung Kim; Hong Bae Jeon; Hoon Lim; Ji Hyun Shin; So Jung Park; Yoon Kyung Jo; Wonil Oh; Yoon Sun Yang; Dong-Hyung Cho; Ju-Yeon Kim
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

10.  Induction of melanogenesis by rapamycin in human MNT-1 melanoma cells.

Authors:  Young-Sool Hah; Hee Young Cho; Tae-Yeon Lim; Dong Hwa Park; Hwa Mi Kim; Jimi Yoon; Jin Gu Kim; Chi Yeon Kim; Tae-Jin Yoon
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.